Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, most people taking antihypertensive medicines can use Mounjaro, but the combination needs prescriber oversight because tirzepatide can itself lower blood pressure as weight falls — meaning your existing doses may need adjusting over time. It is a prescription-only medicine; a clinician assesses your full medication list before treatment starts. Mounjaro (tirzepatide) is a once-weekly injection licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition such as hypertension — so high blood pressure is precisely the kind of comorbidity that may make someone eligible in the first place.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It isn't. Taking tirzepatide alongside a blood pressure medicine is not ruled out by any blanket contraindication in Mounjaro's UK prescribing information. What matters is that your prescriber knows exactly which antihypertensives you take (ACE inhibitors, ARBs, calcium channel blockers, beta-blockers, diuretics, or any combination) because tirzepatide's effect on the body changes the environment those drugs are working in.
Weight loss itself reduces blood pressure. As the weeks progress and your weight falls, your cardiovascular system demands less work, and blood pressure often drops meaningfully. That is good news in principle; the practical implication is that a dose of amlodipine or ramipril calibrated for your pre-treatment weight may become too strong once you have lost 5–10% of your body weight. Lightheadedness on standing, fatigue, or consistently low readings at home are worth flagging to your GP or prescriber promptly, rather than waiting for a routine review. Our guide on Mounjaro and low blood pressure covers those symptoms in detail.
There is also a dehydration angle. Nausea and reduced appetite (particularly common in the early weeks) can mean people eat and drink less than usual. Diuretics (water tablets) can compound this, so staying on top of fluid intake matters. Your prescriber may factor this in when assessing whether your diuretic dose needs a temporary reduction at the start of treatment.
Certain antihypertensives deserve particular attention, though none are automatically incompatible. Diuretics warrant monitoring for dehydration and electrolyte changes, especially if nausea is pronounced in the first few weeks of titration. ACE inhibitors and ARBs are already flagged as medicines to use carefully in any state of reduced fluid intake, for kidney-protection reasons. Beta-blockers can mask some of the warning signs of low blood sugar, relevant mainly if you also take insulin or a sulphonylurea, but worth noting on your medicines list.
Mounjaro slows gastric emptying, which affects how quickly oral medicines are absorbed. For most antihypertensives taken once daily this is unlikely to be clinically significant, but it is a reason to time your tablet-taking consistently. The full picture of medicines to discuss before starting Mounjaro covers a broader range of drug classes, including oral contraceptives and thyroid medicines, where timing or method of administration may need adjustment.
The NHS advises anyone starting a GLP-1 medicine to inform every prescriber involved in their care, including their GP. If your antihypertensive is managed by a hospital specialist or a different clinic, loop them in too, not just because of the interaction question, but because blood-pressure targets may need revising as treatment progresses. NHS England's guidance on weight management injections covers this monitoring expectation directly.
The evidence points to active benefit rather than mere neutrality. In the SURMOUNT clinical trial programme, tirzepatide produced clinically meaningful reductions in systolic blood pressure in participants with obesity, reductions that are partly explained by weight loss and partly by the drug's direct cardiovascular effects. For people with hypertension as their qualifying comorbidity, this matters: the medicine that treats the weight may simultaneously ease the condition that qualified them for it.
That said, individual responses vary considerably. Some people see blood-pressure improvements within the first couple of months; others notice little change until more substantial weight loss has accumulated. A few people, particularly those with masked or stress-related hypertension, may not see the numbers shift as expected. Whether Mounjaro can help with blood pressure directly is a question worth exploring with your prescriber, who can look at your baseline readings alongside your wider cardiovascular picture.
One practical note: if you monitor your blood pressure at home (which many people on antihypertensives do) keep a log from the day you start Mounjaro. Having a two- or three-week trend to share at your first review is far more useful than a single clinic reading taken on a busy morning.
At nume, a named GPhC-registered Independent Prescriber reads your consultation personally, not software, not a template check-list. You'll be asked about every medicine you take, including over-the-counter tablets and supplements. That includes your antihypertensives, their doses, how long you've been on them, and how stable your blood pressure currently is.
If the picture is straightforward, same-day approval is entirely possible. Order before 12pm on a working day and, once clinically cleared, your treatment ships the same afternoon with free tracked DPD delivery arriving the next working day. If a prescriber wants to clarify something with you or your GP first, they will say so, that is the process working as it should, not a barrier.
For context on how treatment costs compare across providers, and what a legitimate private prescription ought to include, the background on Mounjaro's UK pricing is useful reading. And if you're curious about the broader range of weight-loss options available, our weight-loss treatment overview sets out the full picture. When you're ready to discuss your specific medicines list with a prescriber, you can start your free consultation with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.